Elder Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cangene Corporation
U.S. DoD gives notice of intent to purchase human vaccina immune globulin
October 26th, 2005
Cangene announced that the United States Department of Defense (DoD) has published its intention to purchase a supply of Vaccinia Immune Globulin Intravenous (Human) (VIG) from Cangene Corporation. In a presolicitation notice, the DoD indicated that it intends to procure the product from Cangene on a sole-source basis. Cangene has a U.S. Food and Drug Administration (FDA)-licensed VIG product and the manufacturing capability to maintain the DoD's total stockpile requirement. The DoD anticipates issuing a base contract with up to four option years. VIG is a hyperimmune product to be used in treating and preventing a type of severe...
Source: Elder Law Weekly (2005-10-26)
|
